Rubis (LON:0RTS)
 31.48
 +0.04 (0.13%)
  At close: Oct 31, 2025
Rubis Revenue
Rubis had revenue of 3.27B EUR in the half year ending June 30, 2025, a decrease of -1.50%. This brings the company's revenue in the last twelve months to 6.58B, down -0.98% year-over-year. In the year 2024, Rubis had annual revenue of 6.64B with 0.21% growth.
Revenue (ttm) 
 6.58B EUR
Revenue Growth 
 -0.98%
P/S Ratio 
 0.51
Revenue / Employee 
 1.53M EUR
Employees 
 4,299
Market Cap 
2.86B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 6.64B | 13.96M | 0.21% | 
| Dec 31, 2023 | 6.63B | -504.75M | -7.07% | 
| Dec 31, 2022 | 7.13B | 2.55B | 55.46% | 
| Dec 31, 2021 | 4.59B | 687.44M | 17.62% | 
| Dec 31, 2020 | 3.90B | -1.33B | -25.37% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 198.54B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 42.39B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 32.17B | 
| British American Tobacco p.l.c. | 25.60B |